The University of Michigan’s student-led Zull Lurie Commercialisation Fund has made two investments into Michigan companies.
Medtech spin-out Alertwatch, which announced last week that it has received US Food and Drug Administration clearance for its patient monitoring services, and advertising startup Adadapted will both benefit from $90,000 collectively.
The Zull Lurie fund is managed by a team of 25 graduate students, and looks to invest in university-linked businesses in the areas of healthcare, consumer, technology, and cleantech, and typically will invest up to $100,000 in pre-stage funding.
Stewart Thornhill, director of the Zell Lurie Commercialization Fund and executive director of the Zell Lurie Institute, said: “The Zell Lurie Commercialization Fund is as close to a real-world investing experience as any MBA student could possibly receive. Both of these investments demonstrate the strength of the local startup scene and represent the power of the greater U-M community to foster growth within the region. Alertwatch and Adadapted both have tremendous promise to transform their respective industries and deliver a return on our investments.”
